Menu
Not yet recruiting NCT07549087

Motor Imagery Reaction Time in Individuals With Paraplegic Spinal Cord Injury

Observational Spinal Cord Injuries

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: No intervention.
Who it may be relevant to
Registry conditions: Spinal Cord Injuries. Basic parameters: 18 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Upper and Lower Extremity Motor Imagery Reaction Time in Individuals With Paraplegic Spinal Cord Injury: A Comparative Study With Healthy Controls

Overview

Individuals aged 18-65 years who have been clinically diagnosed with spinal cord injury and have developed paraplegia will be included in the study. Demographic and clinical data of the participants, including age, sex, height, weight, etiology of injury, level of injury, duration of injury, and comorbidities, will be recorded. In addition, disease-specific characteristics such as ambulation status, wheelchair use, presence of incontinence, and presence and severity of pain will be assessed. For the healthy control group, demographic data including age, sex, height, weight, and comorbidities will be recorded. Motor imagery performance of the participants will be evaluated using a computer-based left/right judgment task. In this context, both upper extremity (hand) and lower extremity (foot) images will be used to record reaction time (motor imagery reaction time) and accuracy rate. All tests will be performed under standardized conditions, in a seated position, and using the same device.

Interventions

  • Other No intervention
    No intervention

Primary outcome measures

  • Motor Imagery Reaction Time - Upper Extremity [Time frame: Baseline]
  • Motor Imagery Reaction Time - Lower Extremity [Time frame: Baseline]
Secondary outcome measures (3)
  • Functional Independence [Time frame: Baseline]
  • Hospital Anxiety and Depression Scale - Anxiety Subscale (HADS-A) [Time frame: Baseline]
  • Hospital Anxiety and Depression Scale - Depression Subscale (HADS-D) [Time frame: Baseline]

Eligibility criteria

Inclusion criteria

  • Aged between 18 and 65 years
  • Clinically diagnosed with spinal cord injury
  • Presence of paraplegia
  • Injury duration of at least 3 months
  • Medically stable condition
  • Ability to understand and follow study instructions
  • Ability to complete the computer-based left/right judgment task
  • Willingness to participate and provide written informed consent
  • For the healthy control group: age- and sex-compatible individuals without a history of neurological or major musculoskeletal disease, willing to participate and provide written informed consent

Exclusion criteria

  • Tetraplegia
  • History of other neurological disorders that may affect motor imagery performance
  • Severe cognitive impairment or communication problems preventing proper participation
  • Severe visual impairment uncorrected by glasses or lenses
  • Upper or lower extremity musculoskeletal disorders, deformities, or recent injuries that may affect task performance
  • Severe psychiatric disorder
  • Uncontrolled pain or acute medical condition at the time of assessment
  • Current participation in another interventional clinical study

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Study design

Observational model
Case-control

Study locations

Turkey (Türkiye) · 1 center
  • Istanbul Physical Medicine and Rehabilitation Trainig and Research Hospital — Istanbul

Identifiers

NCT: NCT07549087 · istftreah12

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗